Status:
RECRUITING
Strategies for Kidney Outcomes Prevention and Evaluation - The SKOPE Study
Lead Sponsor:
Duke-NUS Graduate Medical School
Conditions:
Chronic Kidney Diseases
Eligibility:
All Genders
40-79 years
Phase:
NA
Brief Summary
Background: Chronic kidney disease (CKD) is a major public health threat associated with significant morbidity, high mortality, and reduced quality of life. However, empirical evidence is limited on s...
Eligibility Criteria
Inclusion
- 3 Inclusion Criteria
- Patients with CKD Stage 3 or Stage 4 defined as persistent reduction in Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula eGFR ≥15 and \< 60 ml/min/1.73m2 for at least 3 months based on two eGFR readings at least 3 months apart and the last eGFR should be measured at least 3 months ago.
- Receiving care at the polyclinics in Singapore for at least one year at the time of recruitment
- Age \>=40 and \<80 years
- Singaporean or permanent resident
- 4 Exclusion Criteria
- On kidney replacement therapy
- Pregnancy or breastfeeding
- Known terminal illness
- Recent hospitalization during last 3 months
- History of leg or foot ulcers, severe mental illness, prior kidney transplant
- Inability to provide informed consent
Exclusion
Key Trial Info
Start Date :
July 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
896 Patients enrolled
Trial Details
Trial ID
NCT05295368
Start Date
July 21 2022
End Date
June 1 2026
Last Update
August 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SingHealth Polyclinics
Singapore, Singapore